Skandinaviska Enskilda Banken (SEB)’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-28,000
Closed -$2.84M 349
2025
Q4
$2.84M Sell
28,000
-304,136
-92% -$24.4M 0.01% 519
2025
Q3
$18.2M Sell
332,136
-44
-0% -$2.2K 0.07% 198
2025
Q2
$17.6M Sell
332,180
-37,549
-10% -$1.91M 0.08% 208
2025
Q1
$16M Hold
369,729
0.08% 205
2024
Q4
$20.8M Hold
369,729
0.09% 171
2024
Q3
$25.2M Hold
369,729
0.12% 148
2024
Q2
$15.6M Buy
369,729
+93
+0% +$5.12K 0.08% 202
2024
Q1
$25.5M Sell
369,636
-61,631
-14% -$3.9M 0.12% 152
2023
Q4
$31.9M Buy
431,267
+197,600
+85% +$13M 0.18% 107
2023
Q3
$15.9M Buy
233,667
+199,222
+578% +$16.9M 0.1% 183
2023
Q2
$3.23M Buy
34,445
+3,102
+10% +$242K 0.02% 446
2023
Q1
$2.13M Buy
31,343
+54
+0.2% +$3.47K 0.01% 540
2022
Q4
$1.55M Buy
31,289
+358
+1% +$14.6K 0.01% 595
2022
Q3
$1M Sell
30,931
-10,314
-25% -$425K 0.01% 681
2022
Q2
$1.63M Buy
41,245
+3,258
+9% +$174K 0.01% 625
2022
Q1
$2.66M Sell
37,987
-6,084
-14% -$445K 0.02% 557
2021
Q4
$3.43M Sell
44,071
-64,600
-59% -$5.7M 0.02% 508
2021
Q3
$10.4M Sell
108,671
-86,006
-44% -$9.08M 0.06% 283
2021
Q2
$24.2M Buy
194,677
+61,662
+46% +$7.36M 0.15% 149
2021
Q1
$17.5M Buy
133,015
+91,655
+222% +$12.5M 0.12% 174
2020
Q4
$5.48M Buy
41,360
+3,180
+8% +$385K 0.04% 347
2020
Q3
$3.89M Buy
38,180
+15,112
+66% +$1.31M 0.03% 387
2020
Q2
$2.01M Buy
23,068
+4,668
+25% +$373K 0.02% 560
2020
Q1
$1.07M Sell
18,400
-20,989
-53% -$1.7M 0.01% 638
2019
Q4
$3.64M Buy
39,389
+21,889
+125% +$1.92M 0.03% 413
2019
Q3
$1.58M Buy
17,500
+2,700
+18% +$308K 0.01% 602
2019
Q2
$1.75M Buy
+14,800
New +$1.49M 0.02% 553

Other funds holding EXAS

Skandinaviska Enskilda Banken (SEB)'s EXAS Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 28,000 shares — an estimated $2.84M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in EXAS in Q2 2019 and held it in 27 quarters. The position peaked at $31.9M in Q4 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 28,000 Exact Sciences shares in Q1 2026, an estimated $2.84M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Exact Sciences in Q2 2019 and held it in 27 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Exact Sciences position peaked at $31.9M in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.